Coinbase CEO Brian Armstrong's longevity biotech startup, Newlimit, has raised $435 million, tripling its valuation to $3.1 billion. This round was led by Founders Fund, indicating growing investor interest in longevity science backed by crypto industry figures.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments